By reducing the addictive properties of cannabis, DRT-101 serves as an innovative solution for effective CUD treatment, particularly beneficial for young adults striving to overcome dependency.
DRT-101 provides a reliable, evidence-based option for individuals using medical cannabis as an alternative to traditional painkillers, minimizing unwanted cognitive and addictive side effects.
We aim for individuals struggling with CUD to find an effective treatment helping them regain control over their lives. Also, we envision a world where cannabinoid-based pain relief and cognitive wellness can harmoniously coexist.
Our candidate, DRT-101, is a first-in-class therapeutic solution, reducing cannabis cravings and addressing the cognitive challenges associated with long-term cannabis use.
We are dedicated to creating groundbreaking solutions for individuals overcoming cannabis addiction.
DRT-101 has been validated in animal models, demonstrating its potential as an impactful solution for CUD treatment
We understand the challenges of recovery and are here to support well-being every step of the way.
Copyright © 2025 Disrupt Therapeutics.
